Drug intelligence / Profile preview

HMGB1 A box

Development stage
Preclinical
Lead developer
Jiangsu University
Modality
Recombinant Proteins and Enzymes
Administration
Intravenous
01

Overview

HMGB1 A box is a recombinant protein fragment corresponding to the A-box domain of the High Mobility Group Box 1 (HMGB1) protein. HMGB1 is a damage-associated molecular pattern (DAMP) that triggers neuroinflammation by binding to receptors such as RAGE and TLR4. The A-box domain acts as a natural competitive antagonist to full-length HMGB1, effectively blocking its pro-inflammatory signaling. In preclinical models of Parkinson's disease, HMGB1 A box has demonstrated the ability to restrict microglia activation, up-regulate the CD200-CD200R signaling axis, and inhibit the differentiation and infiltration of Th17 cells. These actions help restore dopaminergic neurons and reduce inflammatory mediators like TNF-α and IL-1β. It is primarily utilized as a research tool to investigate HMGB1-mediated pathology and is being explored as a potential therapeutic candidate for neuroinflammatory and autoimmune disorders.

Other names
A BoxHMGB1 A-boxHMGB-1 A-boxHMGB 1 A-boxrecombinant HMGB1 A box protein
02

Targets

HMGB1 (High mobility group protein B1)CXCR4 (C-X-C motif chemokine receptor 4)CXCL12 (C-X-C motif chemokine ligand 12)TLR4 (Toll-like receptor 4)TLR9 (Toll-like receptor 9)DNA/RNA (Deoxyribonucleic acid (DNA) and other polyanionic nucleic acids)

Beyond the preview

Go deeper on HMGB1 A box.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HMGB1 A box.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call